Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Trial of a Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

NCT04075435 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT04075435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Trial of a Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia
Lead sponsor
Mclean Hospital
Phase
Phase 1
Overall status
Active, not recruiting
Start date
January 11, 2021
Completion date
December 31, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agitation,psychomotor, alzheimer disease, anxiety, mild cognitive impairment (mci) due to alzheimer's disease